Self management of oral anticoagulant therapy after heart valve replacement

European Journal of Cardio-thoracic Surgery

Volumn 11, Issue 5, 1997, Pages 935-942

  Hasenkam, J M ^a   Kimose, H H ^a   Knudsen, L ^a   Gronnesby H ^a   Halborg, J ^a   Christensen, T D ^a   Attermann, Jørn ^b   Pilegaard, H K ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Anticoagulants; International normalized ratio; Self management

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; HEART VALVE REPLACEMENT; HUMAN; MALE; PATIENT EDUCATION; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY CONTROL; SELF CARE; THROMBOSIS;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION TESTS; BLOOD SPECIMEN COLLECTION; CASE-CONTROL STUDIES; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; SELF ADMINISTRATION; SELF CARE; TIME FACTORS;

EID: 0030946638     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(97)01204-9     Document Type: Article

References (18)

1. Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995;155:2185-2189.
2. Barbui T, Finazzi G, Remuzzi A. Clinical coagulation laboratory and oral anticoagulant therapy treatment. Instrumentation and methodology. Thrombos Haemostas 1995;74:511-514.
3. Bernardo A, Halhuber C, Horstkotte D. Home Prothrombine Estimation. In: Butchart EG, Bodnar E, editors. Thrombosis, Embolism and Bleeding. London: ICR Publishers 1992:325-330.
4. Cannegieter SC, Rosendaal FR, Wintzen AR, Van der Meer FJM, Vandenbroucke JP, Briët E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Eng J Med 1995;333:11-17.
5. Cortelazzo S, Finazzi G, Viero P, Galli M, Remuzzi A, Parenzan L, Barber T. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemostas 1993;4:316-320.
6. Doble N, Baron JH. Anticoagulation control with warfarin by junior hospital doctors. Royal Soc Med 1987;80:627.
7. Hasenkam JM, Knudsen L, Kimose HH, Grønnesby H, Attermann J, Trolle Andersen N, Pilegaard H. Practicability of patient self-testing of oral anticoagulant therapy by the International Normalized Ratio (INR) using a portable whole blood monitor. A pilot investigation. Thromb Res. 1997;85:77-82.
8. Horstkotte D, Piper C, Wiemar M, Schutte HD, Schultheiss H-P. Improvement of prognosis by home prothrombine estimation in patients with life long anticoagulant therapy. XVIIIth Congr. Eur. Soc. Cardiology. Birmingham, August 25-29:1996 (Abstract).
9. Jørgensen T, Danneskiold-Samsøe B, Gotfredsen J, Jespersen J. Anticoagulant Therapy in the Nordic Countries - A Summary Report. NEMT, Danish Hospital Institute 1995, Copenhagen.
10. Kaatz SS, White RH, Hill J, Mascha E, Humphries JE, Becker DM. Accuracy of Laboratory and Portable Monitor International Normalized Ratio Determinations. Comparison with a Criterion Standard. Arch Intern Med 1995;155:1861-1867.
11. Kapiotis S, Quekenberger P, Speiser W. Evaluation of the new method CoaguChek® for determination of prothrombin time from capillary blood: Comparison with Thrombotest® on KC-1. Thromb Res 1995;77:563-567.
12. Kumar S, Haigh JRM, Rhodes LE, Peaker S, Davies JA, Roberts BE, Feely MP. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemostas 1989;62:729-732.
13. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med 1992;152(3):589-92.
14. The European Atrial Fibrillation Trial Study Group: Optimal oral anticoagulant therapy in patients with non-rheumatic atrial fibrillation and recent cerebral ischemia. N Eng J Med 1995;333:5-10.
15. Tripodi A, Arbini AA, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thrombos Haemostas 1993;70:921-924.
16. Van den Besselaar AMHP, Breddin K, Lutze G, Parker-Williams J, Taborski U, Vogel G, Tritschler W, Zerback R, Leinberger R. Multicenter evaluation of a new capillary blood thrombin time monitoring system. Blood Coag Fibrinolysis 1995;6:726-732.
17. Van der Besselaar AMPH. International Standardization of Laboratory Control of Oral Anticoagulant Therapy: A Survey of Thromboplastin Reagents Used for Prothrombine Time Testing. J Heart Valve Dis 1993;2:42-52.
18. White RH, McCurdy SA, Von Marensdorff H, Woodruff DE Jr, Leftgoff L. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Ann Intern Med 1989 Nov 1;111(9):730-7.